awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q30377369-5A61BA79-EC87-47FC-ACE4-3E8732148073
Q30377369-5A61BA79-EC87-47FC-ACE4-3E8732148073
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30377369-5A61BA79-EC87-47FC-ACE4-3E8732148073
Consistency of quality attributes for the glycosylated monoclonal antibody Humira® (adalimumab).
P2860
Q30377369-5A61BA79-EC87-47FC-ACE4-3E8732148073
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30377369-5A61BA79-EC87-47FC-ACE4-3E8732148073
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
400ee4985fee9c92d5b80293ae739e1dcaa45370
P2860
Adalimumab: long-term safety in 23 458 patients from global clinical trials in rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, psoriatic arthritis, psoriasis and Crohn's disease.